Description
Carfilzomib, marketed under the brand name Carfilnat, It is an prescription medication that has been approved carfilzomib in 2012, under its accelerated approval program, for use alone in patients with multiple myeloma whose cancer has progressed after receiving at least two previous therapies, including bortezomib and an immunomodulatory agent (such as lenalidomide or thalidomide).
What is Carfilnat (Carfilzomib) ?
Carfilnat-carfilzomib is indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy.
CARFILNAT is a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Source Content From US FDA
How to order approved “Carfilnat (Carfilzomib) for Injection” Medicine?
Carfilnat (Carfilzomib) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing Carfilnat and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
